Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay (vol 7, 2017)

被引：1

作者：

Hou, Helei ^{[1
]}

Yang, Xiaonan ^{[2
]}

Zhang, Jinping ^{[3
]}

Zhang, Zhe ^{[4
]}

Xu, Xiaomei ^{[5
]}

Zhang, Xiaoping ^{[6
]}

Zhang, Chuantao ^{[1
]}

Liu, Dong ^{[1
]}

Yan, Weihua ^{[7
]}

Zhou, Na ^{[1
]}

Zhu, Hongmei ^{[8
]}

Qian, Zhaoyang ^{[8
]}

Li, Zhuokun ^{[2
]}

Zhang, Xiaochun ^{[1
]}

机构：

[1] Qingdao Univ, Affiliated Hosp, Dept Med Oncol, 16 Jiangsu Rd, Qingdao 266005, Peoples R China

[2] Qingdao SINO GERMAN Ecopk, BGI Qingdao Inst, 2877 Tuanjie Rd, Qingdao 266555, Peoples R China

[3] Univ Texas Houston, Dept Expt Therapeut, South Campus Res Bldg 4,4SCR,Room 4SCR3-2085, Houston, TX 77054 USA

[4] Qingdao Municipal Hosp, Dept Thorac Surg, 1 Jiaozhou Rd, Qingdao 266011, Peoples R China

[5] Qingdao Municipal Hosp, Dept Med Oncol, 5 Donghai Middle Rd, Qingdao 266071, Peoples R China

[6] BGI Shenzhen, Shenzhen 6BGI, Peoples R China

[7] Qingdao Univ, Affiliated Hosp, Dept Pathol, 16 Jiangsu Rd, Qingdao 266005, Peoples R China

[8] BGI Shenzhen, BGI Tianjin, Binhai Genom Inst, Tianjin 300308, Peoples R China

来源：

SCIENTIFIC REPORTS | 2018年 / 8卷

关键词：

D O I：

10.1038/s41598-018-19648-9

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.

引用

页数：1

共 50 条

[1] Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay
Hou, Helei
Yang, Xiaonan
Zhang, Jinping
Zhang, Zhe
Xu, Xiaomei
Zhang, Xiaoping
Zhang, Chuantao
Liu, Dong
Yan, Weihua
Zhou, Na
Zhu, Hongmei
Qian, Zhaoyang
Li, Zhuokun
Zhang, Xiaochun
[J]. SCIENTIFIC REPORTS, 2017, 7
[2] Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay
Helei Hou
Xiaonan Yang
Jinping Zhang
Zhe Zhang
Xiaomei Xu
Xiaoping Zhang
Chuantao Zhang
Dong Liu
Weihua Yan
Na Zhou
Hongmei Zhu
Zhaoyang Qian
Zhuokun Li
Xiaochun Zhang
[J]. Scientific Reports, 7
[3] Publisher Correction: Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay
Helei Hou
Xiaonan Yang
Jinping Zhang
Zhe Zhang
Xiaomei Xu
Xiaoping Zhang
Chuantao Zhang
Dong Liu
Weihua Yan
Na Zhou
Hongmei Zhu
Zhaoyang Qian
Zhuokun Li
Xiaochun Zhang
[J]. Scientific Reports, 8
[4] Discovery of targetable genetic alterations in advanced non-small cell lunge cancer using next generation sequencing-based circulating tumor DNA assay
Hou, Helei
Zhang, Xiaochun
Zhang, Chuantao
Guan, Yanfang
Liu, Dong
Wang, Rongjiao
Li, Zhuokun
Xin, Yi
Xuan, Shiying
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer
Yang, Hua
Zhang, Junjie
Zhang, Lemeng
Wen, Xiaoping
Luo, Yongzhong
Yao, Dingquan
Cheng, Tianli
Cheng, Huanqing
Wang, Huina
Lou, Feng
Guo, Jing
Liang, Xiayuan
Cao, Shanbo
Chen, Jianhua
[J]. ONCOLOGY LETTERS, 2019, 18 (05) : 4762 - 4770
[6] Detection of Actionable Mutation Status in Advanced Non-Small Cell Lung Cancer by Next-Generation Sequencing of Circulating Tumor DNA
Yang, Y.
Song, X.
Guo, W.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S715 - S715
[7] Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer.
Yang, Hua
Zhang, Junjie
Zhang, Lemeng
Wen, Xiaoping
Luo, Yongzhong
Yao, Dingquan
Cheng, Tianli
Cheng, Huanqing
Wang, Huina
Lou, Feng
Guo, Jing
Liang, Xiayuan
Cao, Shanbo
Chen, Jianhua
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[8] Detection of EGFR alterations in circulating tumor DNA of non-small cell lung cancer by digital PCR and Next Generation Sequencing
Malpeli, G.
Simbolo, M.
Pilotto, S.
Lawlor, R. T.
Peretti, U.
Bonizzato, G.
Kinspergher, S.
Ferrara, R.
Cantu, C.
Caccese, M.
Tortora, G.
Bria, E.
Scarpa, A.
[J]. ANNALS OF ONCOLOGY, 2015, 26 : 79 - 79
[9] The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer
Cai, Jun
Jiang, Huihui
Li, Shuqing
Yan, Xiaoxia
Wang, Meng
Li, Na
Zhu, Cuimin
Dong, Hui
Wang, Dongjuan
Xu, Yue
Xie, Hui
Wu, Shouxin
Lou, Jingwei
Zhao, Jiangman
Li, Qingshan
[J]. FRONTIERS IN ONCOLOGY, 2022, 11
[10] Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer
Leprieur, Etienne Giroux
Herbretau, Guillaume
Dumenil, Coraline
Julie, Catherine
Giraud, Violaine
Labrune, Sylvie
Dumoulin, Jennifer
Tisserand, Julie
Emile, Jean-Francois
Blons, Helene
Chinet, Thierry
[J]. ONCOIMMUNOLOGY, 2018, 7 (05):

← 1 2 3 4 5 →